Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Atrion	MiMedx Group	SI-BONE	Tactile Systems Technology	Cerus
Symbol	NASDAQ:ATRI	NASDAQ:MDXG	NASDAQ:SIBN	NASDAQ:TCMD	NASDAQ:CERS
Price Information
Current Price	$614.99	$9.23	$32.81	$52.92	$5.97
52 Week Range	N/A	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.1	1.7	1.5	1.4	1.7
Analysis Score	0.0	3.5	2.5	2.3	3.5
Community Score	2.2	5.0	2.5	2.8	2.9
Dividend Score	1.7	0.0	0.0	0.0	0.0
Ownership Score	0.8	0.0	1.7	0.0	1.7
Earnings & Valuation Score	0.6	0.0	0.6	1.9	0.6
Analyst Ratings
Consensus Recommendation	N/A	Buy	Buy	Buy	Buy
Consensus Price Target	N/A	$20.00	$38.43	$59.00	$8.50
% Upside from Price Target	N/A	116.68% upside	17.12% upside	11.49% upside	42.38% upside
Trade Information
Market Cap	$1.11 billion	$1.03 billion	$1.03 billion	$1.03 billion	$990.23 million
Beta	0.13	1.71	1.41	1.69	1.37
Average Volume	7,507	550,914	283,597	156,751	2,142,526
Sales & Book Value
Annual Revenue	$155.07 million	$299.26 million	$67.30 million	$189.49 million	$74.65 million
Price / Sales	7.25	3.45	16.00	5.49	13.69
Cashflow	$21.51 per share	N/A	N/A	$0.78 per share	N/A
Price / Cash	28.59	N/A	N/A	68.21	N/A
Book Value	$128.24 per share	$0.31 per share	$2.52 per share	$5.92 per share	$0.41 per share
Price / Book	4.80	29.77	13.02	8.94	14.56
Profitability
Net Income	$36.76 million	$-25,580,000.00	$-38,400,000.00	$10.97 million	$-71,240,000.00
EPS	N/A	N/A	($1.55)	$0.56	($0.51)
Trailing P/E Ratio	34.65	N/A	N/A	N/A	N/A
Forward P/E Ratio	∞	∞	N/A	160.36	N/A
P/E Growth	N/A	N/A	N/A	10.36	N/A
Net Margins	21.90%	-37.28%	-61.67%	-4.57%	-73.72%
Return on Equity (ROE)	13.90%	-404.08%	-45.03%	1.37%	-63.47%
Return on Assets (ROA)	12.55%	-58.81%	-29.29%	0.99%	-30.82%
Dividend
Annual Payout	$7.00	N/A	N/A	N/A	N/A
Dividend Yield	1.14%	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	46.67%	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	17 Years	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	3.70%	0.39%	N/A	0.36%
Current Ratio	8.91%	2.99%	12.65%	4.45%	3.84%
Quick Ratio	5.08%	2.80%	12.22%	3.58%	3.42%
Ownership Information
Institutional Ownership Percentage	63.17%	4.03%	65.26%	N/A	82.06%
Insider Ownership Percentage	22.44%	19.80%	15.50%	5.30%	6.49%
Miscellaneous
Employees	636	735	295	707	254
Shares Outstanding	1.83 million	111.93 million	32.81 million	19.65 million	171.17 million
Next Earnings Date	8/5/2021 (Estimated)	8/3/2021 (Estimated)	8/2/2021 (Estimated)	8/2/2021 (Estimated)	8/3/2021 (Estimated)
Optionable	Not Optionable	Optionable	Not Optionable	Optionable	Optionable

Source	Headline
	Cerus (NASDAQ:CERS) Issues FY 2021 Earnings Guidance americanbankingnews.com - May 18 at 10:48 AM
	Other news to note for May 17, 2021 \| 2021-05-17 - BioWorld Online bioworld.com - May 17 at 7:26 PM
	Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets - BioSpace biospace.com - May 17 at 7:26 PM
	Comprehensive Report on Apheresis Machines Market 2021 \| Trends, Growth Demand, Opportunities & Forecast To 2027 \| Kaneka Corporation, Cerus Corporation, Kawasumi Laboratories Inc., Haemonetics Corporation – Test & Measurement - Test & Measurement testmeasurement.com.au - May 17 at 9:25 AM
	Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets - Yahoo Finance finance.yahoo.com - May 17 at 9:25 AM
	Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets finance.yahoo.com - May 17 at 9:25 AM
	Zika Vaccines Sales Market 2021 Worldwide Industry Share, Size, Gross Margin, Trend, Future Demand, Analysis By Top Leading Player And Forecast Till 2027\| Bharat Biotech, Inovio Pharmaceuticals, Cerus Corporation – Test & Measurement - Test & Measurement testmeasurement.com.au - May 14 at 8:16 AM
	Blood Purification Equipment Market to Witness Huge Growth by 2027 \| Cerus Corp Company, Aethlon Medical Inc, Spectral Medical Inc – Clark County Blog - Clark County Blog clarkcountyblog.com - May 13 at 5:48 PM
	Cerus (NASDAQ:CERS) Releases FY 2021 Earnings Guidance americanbankingnews.com - May 11 at 8:54 AM
	Massive Growth of Apheresis Market by 2026 \| Cerus Corporation, Fresenius Se & Co. Kgaa, Asahi Kasei Medical Co., Ltd. (A Subsidiary Of Asa, Haemonetics Corporation, Terumo Bct – Brockville Observer - Brockville Observer thebrockvilleobserver.ca - May 11 at 12:03 AM
	Cerus: Q1 Earnings Snapshot myrtlebeachonline.com - May 8 at 2:06 PM
	Analysts Offer Insights on Healthcare Companies: Cerus (CERS), EyePoint Pharmaceuticals (EYPT) and Arbutus Biopharma (ABUS) - Smarter Analyst smarteranalyst.com - May 6 at 12:57 PM
	Cerus (NASDAQ:CERS) Announces Quarterly Earnings Results americanbankingnews.com - May 5 at 7:01 PM
	Cerus (NASDAQ:CERS) Shares Up 9.3% americanbankingnews.com - May 5 at 12:26 PM
	Cerus Corporation (CERS) CEO Obi Greenman on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha seekingalpha.com - May 5 at 11:49 AM
	Should You Buy Cerus Corporation (CERS) Stock After it Is Down 4.52% in a Week? - InvestorsObserver investorsobserver.com - May 5 at 11:49 AM
	Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript - Motley Fool fool.com - May 5 at 11:49 AM
	Cerus: Q1 Earnings Snapshot - Miami Herald miamiherald.com - May 5 at 11:49 AM
	Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript fool.com - May 5 at 9:44 AM
	Cerus Target of Unusually High Options Trading (NASDAQ:CERS) americanbankingnews.com - May 5 at 6:58 AM
	Cerus: Q1 Earnings Snapshot - The Edwardsville Intelligencer theintelligencer.com - May 4 at 11:55 PM
	Cerus Corp. to Host Earnings Call - Yahoo Finance finance.yahoo.com - May 4 at 6:54 PM
	Cerus: Q1 Earnings Snapshot - Beaumont Enterprise beaumontenterprise.com - May 4 at 6:54 PM
	Cerus Corporation Announces First Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance - Business Wire businesswire.com - May 4 at 6:54 PM
	Blood Plasma Products market expecting to reach highest cagr till 2025: Takeda Pharmaceutical Company, Baxter International Inc., Innovative Research, Inc., Cerus Corporation, Octapharma AG, ADMA Biologics Inc., and ARTHREX INC. - Clark County Blog clarkcountyblog.com - May 4 at 8:53 AM

Date	Company	Brokerage	Action
3/25/2021	MiMedx Group	HC Wainwright	Initiated Coverage
5/10/2021	SI-BONE	Needham & Company LLC	Boost Price Target
5/10/2021	SI-BONE	Morgan Stanley	Boost Price Target
5/10/2021	SI-BONE	Canaccord Genuity	Boost Price Target
5/4/2021	SI-BONE	Truist Securities	Boost Price Target
1/8/2021	SI-BONE	JMP Securities	Boost Price Target
6/15/2020	SI-BONE	Cantor Fitzgerald	Initiated Coverage
1/25/2021	Tactile Systems Technology	BTIG Research	Boost Price Target
11/13/2020	Tactile Systems Technology	Oppenheimer	Upgrade
4/6/2020	Tactile Systems Technology	Piper Sandler	Reiterated Rating
11/18/2019	Tactile Systems Technology	Piper Jaffray Companies	Initiated Coverage
6/13/2019	Tactile Systems Technology	Dougherty & Co	Initiated Coverage
5/7/2019	Tactile Systems Technology	Guggenheim	Boost Price Target
3/22/2019	Tactile Systems Technology	Northland Securities	Reiterated Rating
5/27/2020	Cerus	Stifel Nicolaus	Boost Price Target
4/16/2020	Cerus	Stephens	Lower Price Target
8/3/2018	Cerus	Cowen	Set Price Target

(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources